Changes in pulmonary cytokines during antibiotic therapy for ventilator-associated pneumonia

Surgical Infections

Volumn 11, Issue 2, 2010, Pages 161-167

  Swanson, Joseph M ^a   Mueller, Eric W ^b   Croce, Martin A ^a   Wood, G Christopher ^a   Boucher, Bradley A ^a   Magnotti, Louis J ^a   Fabian, Timothy C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFEPIME; INTERLEUKIN 8; SULBACTAM; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; COLONY FORMING UNIT; CRITICALLY ILL PATIENT; FEMALE; HUMAN; LUNG LAVAGE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; VENTILATOR ASSOCIATED PNEUMONIA; BACTERIAL COUNT; BACTERIUM; CHEMISTRY; DRUG MONITORING; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PILOT STUDY;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; BRONCHOALVEOLAR LAVAGE FLUID; COLONY COUNT, MICROBIAL; DRUG MONITORING; FEMALE; HUMANS; INTERLEUKIN-8; LUNG; MALE; MIDDLE AGED; PILOT PROJECTS; PNEUMONIA, VENTILATOR-ASSOCIATED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77953725580     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2008.067     Document Type: Article

References (30)

1. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990;141: 765-788.
3. Kolsuz M, Erginel S, Alatas O, et al. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia. Respiration 2003;70:615-622.
4. Millo JL, Schultz MJ, Williams C, et al. Compartmentalisation of cytokines and cytokine inhibitors in ventilatorassociated pneumonia. Intensive Care Med 2004;30:68-74.
5. Dehoux MS, Boutten A, Ostinelli J, et al. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994;150:710-716.
6. Boutten A, Dehoux MS, Seta N, et al. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1996;153:336-342.
7. Monton C, Torres A. Lung inflammatory response in pneumonia. Monaldi Arch Chest Dis 1998;53:56-63.
8. Wunderink RG. Clinical criteria in the diagnosis of ventilatorassociated pneumonia. Chest 2000;117:191S-194S.
9. Croce MA, Fabian TC, Schurr MJ, et al. Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: A prospective analysis. J Trauma 1995;39:1134-1139.
10. Miller PR, Meredith JW, Chang MC. Optimal threshold for diagnosis of ventilator-associated pneumonia using bronchoalveolar lavage. J Trauma 2003;55:263-267.
11. Croce MA, Fabian TC, Mueller EW, et al. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma 2004;56:931-934.
12. Bernard GR, Artigas A, Brigham KL, et al. The American- European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824.
13. Croce MA, Fabian TC, Waddle-Smith L, et al. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: A prospective study. Ann Surg 1998; 227:743-751.
14. Kiehl MG, Ostermann H, Thomas M, et al. Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med 1998;26:1194-1199. (Pubitemid 28334972)
15. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986;60: 532-538.
16. Mueller EW, Croce MA, Boucher BA, et al. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilatorassociated pneumonia. J Trauma 2007;63:1329-1337.
17. Monton C, Torres A, El-Ebiary M, et al. Cytokine expression in severe pneumonia: A bronchoalveolar lavage study. Crit Care Med 1999;27:1745-1753.
18. Schütte H, Lohmeyer J, Rosseau S, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996;9:1858-1867.
19. Gibot S, Cravoisy A, Levy B, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004;350:451-458.
20. Dennesen PJ, van der Ven AJ, Kessels AG, et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001;163:1371-1375.
21. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003;290: 2588-2598.
22. Croce MA, Swanson JM, Magnotti LJ, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma 2006;60:523-527.
23. El Solh AA, Akinnusi ME, Wiener-Kronish JP, et al. Persistent infection with Pseudomonas aeruginosa in ventilatorassociated pneumonia. Am J Respir Crit Care Med 2008;178: 513-519.
24. Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, et al. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 1994;22:55-60.
25. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 2006;174:84-93.
26. Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial. Am J Respir Crit Care Med 2008;177:498-505.
27. Hochreiter M, Kohler T, Schweiger AM, et al. [Antibiotic treatment of surgical intensive care patients: Procalcitonin to guide duration of therapy](Ger). Anaesthesist 2008;57:571-577.
28. Seligman R, Meisner M, Lisboa TC, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006;10:R125.
29. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005;171:48-53.
30. Duflo F, Debon R, Monneret G, et al. Alveolar and serum procalcitonin: Diagnostic and prognostic value in ventilatorassociated pneumonia. Anesthesiology 2002;96:74-79.